Adherium receives U.S. FDA 510(k) clearance for GSK pMDI inhaler users to remotely monitor physiological parameters

/in

Melbourne, Australia – 28 November 2022: (Link Here) Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced that is has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market application, connecting GlaxoSmithKline’s (GSK) Ventolin®, Advair®, and Flovent® pressurised metered dose inhaler (pMDI) users with […]

Read more

Graybug and CalciMedica Enter into Definitive Merger Agreement

/in

November 21, 2022 18:52 ET | Source: Graybug Vision, Inc.; CalciMedica Inc. Link here  Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing CalciMedica’s pipeline of first-in-class product candidates for life-threatening inflammatory diseases Combined company is expected to be funded with cash and cash equivalents of approximately $35 million at closing, with an expected runway into […]

Read more

Tragedy behind Australia’s world-class burns technology treatment RECELL: Robert Gottliebsen

/in

The Australian, Tuesday, November 8, 2022, Link Here: One of Australia’s best known, and most successful medical breakthroughs has been the burns treatment process developed in Western Australia, which was highlighted after the 2002 Bali bombings. But it is also one of the most tragic. The US has now embraced the Australian technology as its […]

Read more